The Company

Sur180 Therapeutics is a Research and Development Startup in the therapeutics field focusing on new therapies for endometriosis.

The Team

We are a neuroscientist, a gastrointestinal physiologist and a molecular biologist, working together for more than a decade.

For patients

We want to hear from you! Please send us an e-mail to the address shown below. We can provide you with more information about our ongoing research efforts.

Strategy

• Repurpose drugs that have not been explored for treating endometriosis.
• Think of endometrosis as a systemic disease.
• Explore new pathophysiological pathways.

Growth

“We can’t reach where we need to be by remaining where we are“

Quote modified from Oprah Winfrey

Success

Providing new therapeutic options for endometriosis, beyond the usual hormonal treatments. We believe in change by testing new treatments outside the norm.